Pesquisas alternativas:
model develop » model develops (Expandir a Pesquisa), models develop (Expandir a Pesquisa), model developed (Expandir a Pesquisa)
cross develop » cross developed (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), across developed (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drug model » drug models (Expandir a Pesquisa), drug mode (Expandir a Pesquisa)
drug cross » drugs cross (Expandir a Pesquisa), drugs across (Expandir a Pesquisa), drug class (Expandir a Pesquisa)
model develop » model develops (Expandir a Pesquisa), models develop (Expandir a Pesquisa), model developed (Expandir a Pesquisa)
cross develop » cross developed (Expandir a Pesquisa), loss develop (Expandir a Pesquisa), across developed (Expandir a Pesquisa)
develop type » developing type (Expandir a Pesquisa)
drug model » drug models (Expandir a Pesquisa), drug mode (Expandir a Pesquisa)
drug cross » drugs cross (Expandir a Pesquisa), drugs across (Expandir a Pesquisa), drug class (Expandir a Pesquisa)
161
Por Burns, David P., Canavan, Leonie, Rowland, Jane, O'Flaherty, Robin, Brannock, Molly, Drummond, Sarah E., O'Malley, Dervla, Edge, Deirdre, O'Halloran, Ken D.
Publicado no J Physiol (2018)
“...‐treatment preserved MyHC type IIx complement in mdx muscle. Drug co‐treatment increased the cross‐sectional...”Publicado no J Physiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
162
“... intermittently. The term extended-MDR has been used to describe this type of broad drug cross resistance. Here we...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
163
Por Tang, Jing, Karhinen, Leena, Xu, Tao, Szwajda, Agnieszka, Yadav, Bhagwan, Wennerberg, Krister, Aittokallio, Tero
Publicado em 2013
“...A recent trend in drug development is to identify drug combinations or multi-target agents...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
164
“... aimed to develop a model based on the random walk on hypergraph for microbe-disease association...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
165
Por Christopher R Heier, Alfredo D Guerron, Alexandru Korotcov, Stephen Lin, Heather Gordish-Dressman, Stanley Fricke, Raymond W Sze, Eric P Hoffman, Paul Wang, Kanneboyina Nagaraju
Publicado em 2014-01-01
“... that causes DMD and is routinely used for preclinical drug testing. There is a need to develop sensitive, non...”Publicado em 2014-01-01
Obter o texto integral
Artigo
166
Por Kang, Guoxin, Giovannone, Steven F., Liu, Nian, Liu, Fang-Yu, Zhang, Jie, Priori, Silvia G., Fishman, Glenn I.
Publicado em 2010
“... crossed RyR2(R4496C/+) knock-in mice with the newly described Cntn2-EGFP BAC transgenic mice, which...”Publicado em 2010
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
167
“... to 15.4) for drug-induced akathisia. The result of the final model found out drug-induced parkinsonism...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
168
Por Amorim, Jaime Henrique, Pereira Bizerra, Raíza Sales, dos Santos Alves, Rúbens Prince, Sbrogio-Almeida, Maria Elisabete, Levi, José Eduardo, Capurro, Margareth Lara, de Souza Ferreira, Luís Carlos
Publicado em 2012
“... to tropical and subtropical regions. There is currently no effective drug or vaccine formulation...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
169
Por Heier, Christopher R., Guerron, Alfredo D., Korotcov, Alexandru, Lin, Stephen, Gordish-Dressman, Heather, Fricke, Stanley, Sze, Raymond W., Hoffman, Eric P., Wang, Paul, Nagaraju, Kanneboyina
Publicado no PLoS One (2014)
“... that causes DMD and is routinely used for preclinical drug testing. There is a need to develop sensitive, non...”Publicado no PLoS One (2014)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
170
Por Mescalchin, Alessandra, Wünsche, Winfried, Laufer, Sandra D., Grohmann, Dina, Restle, Tobias, Sczakiel, Georg
Publicado em 2006
“... model target. Ultraviolet (UV) cross-linking studies and competition experiments with primer/template...”Publicado em 2006
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
171
Por Zhang, Chen, Li, Xiaoming, Liu, Yu, Qiao, Shan, Zhang, Liying, Zhou, Yuejiao, Tang, Zhenzhu, Shen, Zhiyong, Chen, Yi
Publicado no PLoS One (2016)
“... contracted HIV from “blamable” routes (e.g., injection drug use, sex with sex workers). A cross-sectional...”Publicado no PLoS One (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
172
Por Simonyan, Tamara, Papyan, Ruzanna, Danielyan, Samvel, Sargsyan, Lilit, Grigoryan, Varduhi, Topchyan, Hakob, Azaryan, Arpina, Tananyan, Armen, Muradyan, Armen, Tamamyan, Gevorg
Publicado no Asian Pac J Cancer Prev (2019)
“... of Health of the Republic of Armenia (MOH). Simultaneously, detailed information about the drugs, on type...”Publicado no Asian Pac J Cancer Prev (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
173
“... pure RF model developed based on the full descriptors was performed as well for the same data set...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
174
Por Kasap, Metin, Canaz, Huseyin, Canaz, Gokhan, Tokmak, Mehmet, Bingul, Alper, Alatas, Ibrahim
Publicado no Asian J Neurosurg (2018)
“...). Luminal cross-sectional areas of the drug-treated groups did not differ from each other. Mean luminal...”Publicado no Asian J Neurosurg (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
175
“... that more effective inhibitors could be developed. Using a computer model of HIV-1 RT we performed docking...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
176
Publicado em 1977
“... anesthetics must cross a hydrophobic barrier to reach their receptor. A model representing diffusion of drug...”Obter o texto integral
Obter o texto integral
Artigo
177
“...<p>Precision medicine (PM), a new type of medical concept and model which based on personalized...”
Obter o texto integral
Obter o texto integral
Artigo
178
Por Delicano, Rachel Ann, Hammar, Ulf, Egenvall, Agneta, Westgarth, Carri, Mubanga, Mwenya, Byberg, Liisa, Fall, Tove, Kennedy, Beatrice
Publicado no BMJ (2020)
“... crossing the null (1.11, 0.87 to 1.42). No association was found between type 2 diabetes in cat owners...”Publicado no BMJ (2020)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
179
Por Ealand, Christopher, Rimal, Binayak, Chang, James, Mashigo, Lethabo, Chengalroyen, Melissa, Mapela, Lusanda, Beukes, Germar, Machowski, Edith, Kim, Sung Joon, Kana, Bavesh
Publicado no Appl Environ Microbiol (2018)
“... formation, which is used as a model to study drug tolerance and bacterial signaling in mycobacteria. We...”Publicado no Appl Environ Microbiol (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
180
Por van der Aart-van der Beek, Annemarie B., Koomen, Jeroen V., Dekkers, Claire C. J., Barbour, Sean J., Boulton, David W., Gansevoort, Ron T., Greasley, Peter J., Abdul Gafor, Abdul Halim, Laverman, Gozewijn D., Li, Qiang, Lim, Soo Kun, Stevens, Jasper, Vervloet, Marc G., Singh, Sunita, Cattran, Daniel C., Reich, Heather N., Cherney, David Z. I., Heerspink, Hiddo J. L.
Publicado no Clin Pharmacokinet (2021)
“... developed as an oral glucose-lowering drug for the treatment of type 2 diabetes mellitus. Emerging data...”Publicado no Clin Pharmacokinet (2021)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo